Melanie Sena

Melanie Sena is community editor of Pharmaceutical Technology.


AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes

AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.

Novartis to License Google "Smart Lens" Technology

Alcon enters agreement with Google to in-license its "smart lens" technology for all ocular medical uses.

Lilly and Immunocore Enter Immunotherapy Agreement

Lilly and Immunocore enter immunotherapy agreement to co-discover and co-develop new cancer therapies.

AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters

AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.

Medicenna Therapeutics Selects Kalon Biotherapeutics To Manufacture New Cancer Drug

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

More than 430 New Medicines in Development for Chronic Diseases

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

National Bioscience Report Reveals Positive Trends for Bioscience Industry

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.

NIH launches 3D Print Exchange for Researchers

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Big Pharma Industry Shrinks While Biotech Booms

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.